What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
Ikuo Konishi mainly focuses on Cancer research, Pathology, Internal medicine, Ovarian cancer and Endocrinology.
Ikuo Konishi interconnects Cell growth, DNA methylation, Ovarian carcinoma, Carcinogenesis and Downregulation and upregulation in the investigation of issues within Cancer research.
Pathology is closely attributed to Adenocarcinoma in his study.
His studies deal with areas such as Cyclopamine, Hedgehog signaling pathway, Progesterone receptor and Oncology as well as Internal medicine.
His Ovarian cancer study combines topics from a wide range of disciplines, such as Tumor microenvironment, Vascular endothelial growth factor, Antibody, Immunology and Snail.
His work deals with themes such as Receptor, Mesenchymal stem cell, Transplantation and Pregnancy, which intersect with Endocrinology.
His most cited work include:
- Safety and Antitumor Activity of Anti–PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer (579 citations)
- Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels. (316 citations)
- IFN-γ From Lymphocytes Induces PD-L1 Expression and Promotes Progression of Ovarian Cancer (308 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Pathology, Cancer research, Ovarian cancer and Endocrinology.
His work in Internal medicine covers topics such as Oncology which are related to areas like Cervical cancer.
His Pathology research includes elements of Ovary, Uterus and Adenocarcinoma.
His work in Cancer research addresses subjects such as Ovarian carcinoma, which are connected to disciplines such as Serous fluid.
His Ovarian cancer study incorporates themes from Immunology and Cisplatin.
His research in Endocrinology intersects with topics in Fetus, Placenta and Progesterone receptor.
He most often published in these fields:
- Internal medicine (30.94%)
- Pathology (26.15%)
- Cancer research (21.36%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (30.94%)
- Ovarian cancer (18.05%)
- Cancer research (21.36%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Ovarian cancer, Cancer research, Oncology and Cancer are his primary areas of study.
His Internal medicine research incorporates themes from Gastroenterology and Endocrinology.
His studies in Ovarian cancer integrate themes in fields like Cell, Chemotherapy, Cisplatin, Immunology and Gene.
The concepts of his Cancer research study are interwoven with issues in Cell culture, CD8, Cell growth and Myeloid-derived Suppressor Cell.
His Oncology research includes elements of Clear cell carcinoma, Ovarian carcinoma, Carboplatin, Randomized controlled trial and Serous fluid.
His Pathology research is multidisciplinary, relying on both Gene expression and Nuclear medicine.
Between 2015 and 2021, his most popular works were:
- Dual Faces of IFNγ in Cancer Progression: A Role of PD-L1 Induction in the Determination of Pro- and Antitumor Immunity (176 citations)
- PD-1/PD-L1 blockade in cancer treatment: perspectives and issues (155 citations)
- Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibits Tumor Immunity through the Accumulation of Myeloid-Derived Suppressor Cells (114 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
The scientist’s investigation covers issues in Immunology, Internal medicine, Cancer research, Ovarian cancer and Oncology.
His Immunology course of study focuses on Cancer and Gynecologic oncology.
His studies deal with areas such as Endocrinology, Heterologous and Sarcoma as well as Internal medicine.
Ikuo Konishi combines subjects such as Immunohistochemistry, Cell growth, Downregulation and upregulation, CD8 and Myeloid-derived Suppressor Cell with his study of Cancer research.
His work carried out in the field of Ovarian cancer brings together such families of science as Cell, Cisplatin, Bioinformatics, Regimen and Serous fluid.
His biological study deals with issues like Stage, which deal with fields such as Laparotomy, Debulking and Chemotherapy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
